Interpace Biosciences, Inc. (IDXG)
1.95
-0.05
(-2.50%)
USD |
OTCM |
May 08, 13:48
Interpace Biosciences Research and Development Expense (Annual) : 0.642M for Dec. 31, 2025
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Biodesix, Inc. | 12.00M |
| FONAR Corp. | 1.576M |
| Thermo Fisher Scientific, Inc. | 1.397B |
| Innovative MedTech, Inc. | -- |
| Meridian Holdings, Inc. (California) | -- |